Medtronic (NYSE:MDT) CEO Omar Ishrak today unveiled what the medical device giant's management structure will look like after it closes its mega-merger with Covidien (NYSE:COV) early next year.
According to an employee presentation filed with the SEC, the 'new' Medtronic will be comprised of 4 major business segments, headed by Medtronic's 3 existing group presidents, plus Covidien group president Bryan Hanson.
The Covidien group is slated to oversee all of that company's current businesses except 2: Covidien's peripheral vascular business will be merged into Medtronic's aortic and peripheral unit, while Covidien's neurovascular business will function as a unit of Medtronic's restorative therapies group.
Help employers find you! Check out all the jobs and post your resume.
According to an employee presentation filed with the SEC, the 'new' Medtronic will be comprised of 4 major business segments, headed by Medtronic's 3 existing group presidents, plus Covidien group president Bryan Hanson.
The Covidien group is slated to oversee all of that company's current businesses except 2: Covidien's peripheral vascular business will be merged into Medtronic's aortic and peripheral unit, while Covidien's neurovascular business will function as a unit of Medtronic's restorative therapies group.
Help employers find you! Check out all the jobs and post your resume.